Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection? - Wikidata - awgldk - TriplyDB

Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?

Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?

http://www.wikidata.org/entity/Q37328464

about

Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B.Interleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells.IL-33/ST2 Axis in Organ Fibrosis

P2860

Q28069174-B44D5C00-D1E2-4108-85E9-AD7D43C52984 Q30368428-34C9C0E1-476F-46FC-BA89-6C2D86422C49 Q42695116-7B34408C-B23D-4CCF-A167-DF220A79268E Q45863196-0CDCF1FE-56FB-458E-B7E3-BC3DC9FC1D69 Q58566658-7A409589-DD7F-44B5-BA2C-56C4D6A1F6D8

P2860

Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?

http://www.wikidata.org/entity/Q37328464

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?

@en

Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?

@nl

type

label

Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?

@en

Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?

@nl

prefLabel

Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?

@en

Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?

@nl

P1433

Q37328464-DF1FD7EA-C5CF-4BCE-842F-04C6BC505F2E

P1476

Q37328464-CFEEB22A-EEA3-456B-A463-A9F87B105A2E

P2093

Q37328464-2B8C0046-C406-497A-8036-F8A6388AC89A

Q37328464-3B42DBD5-54A8-4128-B37D-3E5CFBD60392

Q37328464-4ADF1E96-461B-424F-B975-333B79D16A1C

Q37328464-79D5C50F-F0EA-43E5-827E-A29B29C5ECAF

Q37328464-90A438A5-E1BC-4EC6-9799-62627FA247C0

Q37328464-94F4BAB8-74A9-4F54-84CB-BE639D9A3B5F

Q37328464-9BC8B53A-91D4-4E32-B93E-BCC478B35248

Q37328464-9D59D1C9-D8D2-4D17-A916-08E4004D72E3

Q37328464-A384A986-41A3-4043-8361-3CC706F73C91

Q37328464-ADF8CA8A-E44A-4FCC-A7C6-D9BEFA0ABE0F

P2860

Q37328464-064D47E9-7263-4871-9470-5FB0FF789DB6

Q37328464-06937DF3-64F3-4F4F-B0A6-6D43F02208BC

Q37328464-0CD4F632-53AC-4C74-9198-67FE619A3397

Q37328464-1888E4E9-A41B-4D7D-87C8-847D7C6F41E6

Q37328464-1B0307ED-F743-4AA4-ADDB-3D93069CA4A5

Q37328464-1BA41D25-2788-4749-8499-E3A401E8342A

Q37328464-1CA91686-56D2-434B-BE8D-62129D3158B7

Q37328464-1DA10551-F8DB-4830-8C1E-A97559FB169C

Q37328464-2B0402EE-550C-4492-B622-51701CDE0163

Q37328464-34C1895B-3A45-4C5D-B5D3-E9476C0E5C92

P304

Q37328464-D10EF423-7B2D-45A9-B423-A897E7EE01C9

P31

Q37328464-7C2725D4-B574-45D0-87A8-F07C3795AED8

P356

Q37328464-BDE21D19-3595-4A54-BB69-7CE48888E08F

P407

Q37328464-4044C97B-AAAD-4F84-9BF3-66A2D413BC69

P433

Q37328464-2775344F-0432-4321-A016-2896DF4FC5E9

P478

Q37328464-0DE805E1-577F-4E15-BEB6-84A51B30F70A

P577

Q37328464-47AD7F97-B0DC-40F2-8DED-4897C3F4EE69

P698

Q37328464-09CF66E5-C71C-428A-8C9D-86242C59E6C8

P932

Q37328464-43058FFB-ADEE-494D-A27F-7D51F1CBC454

P356

MD.0000000000001889

P1433

P1476

Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?

@en

P2093

Aydin Seref Koksal

http://www.w3.org/2001/XMLSchema#string

Bulent Odemis

http://www.w3.org/2001/XMLSchema#string

Erkin Oztas

http://www.w3.org/2001/XMLSchema#string

Ertugrul Kayacetin

http://www.w3.org/2001/XMLSchema#string

Fatih Oguz Onder

http://www.w3.org/2001/XMLSchema#string

Hakan Yildiz

http://www.w3.org/2001/XMLSchema#string

Huseyin Tugrul Celik

http://www.w3.org/2001/XMLSchema#string

Ismail Hakki Kalkan

http://www.w3.org/2001/XMLSchema#string

Meral Akdogan

http://www.w3.org/2001/XMLSchema#string

Mesut Yalin Kilic

http://www.w3.org/2001/XMLSchema#string

P2860

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules

Global epidemiology of hepatitis B virus

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations.

Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: a comparative study.

Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso.

Identification of serum soluble ST2 receptor as a novel heart failure biomarker.

P304

e1889

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000001889

http://www.w3.org/2001/XMLSchema#string

P407

P433

47

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26632683

http://www.w3.org/2001/XMLSchema#string

P932

5058952

http://www.w3.org/2001/XMLSchema#string